Product Description
Rebopag 25mg Tablet is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It is also used to treat severe aplastic anemia.
Rebopag 25mg Tablet is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. The function of platelets is to help reduce bleeding.
Take it in the exact dose and duration as advised by the doctor. You may take it on an empty stomach. This medicine is to be swallowed as a whole. Do not chew, crush or break it. Inform your doctor if you have any known allergies to this medication.
The common side effects include nausea, vomiting, diarrhea, upper respiratory tract infection, and urinary tract infection. Let your doctor know if any of these side effects bother you. They may be able able to suggest ways to reduce or treat the symptoms.
Before you take this medicine, inform your doctor if you have any preexisting medical conditions. Let your doctor also know about all the other medicines you are taking. Dose adjustments may be required in patients with liver diseases, inform your doctor.
Uses of Rebopag Tablet
Benefits of Rebopag Tablet
In Low platelet count due to ITP or HCV infection
Rebopag 25mg Tablet is used to increase the number of platelets (cells that help the blood clot) to decrease the risk of bleeding in adults and children 1 year of age and older who have chronic idiopathic thrombocytopenic purpura (ITP, an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood). It is used in patients who have not benefited or cannot be treated with other treatments, including medications or surgery to remove the spleen. Rebopag 25mg Tablet is also used to increase the number of platelets in people who have hepatitis C (a viral infection that may damage the liver). It is usually given along with other medicines.
Comprehensive Platelet ManagementEltrombopag Tablets offer an effective solution for adults dealing with low platelet counts due to chronic immune thrombocytopenia or Hepatitis C. As a thrombopoietin receptor agonist, these tablets encourage the bone marrow to produce more platelets, supporting better disease management and lowering the risk of complications. Speak with your healthcare provider to understand if Eltrombopag is suitable for your condition and how it fits into your overall treatment plan.
Simple Oral Dosage and Flexible PackagingAdministered orally, Eltrombopag Tablets are easy to incorporate into daily routines. With various tablet strengths and packaging options like 7, 14, or 28 count packs, patients can follow their physicians precise recommendations for effective dosage. Always swallow whole tabletsdo not crush or chew. This flexibility in packaging supports all users, from individuals to healthcare organizations.
FAQs of Eltrombopag Tablet:
Q: How should Eltrombopag Tablets be taken?
A: Eltrombopag Tablets must be taken orally and swallowed whole with water, as prescribed by your physician. Do not crush or chew the tablets, and always follow your doctors dosage instructions for optimal efficacy.
Q: What conditions are Eltrombopag Tablets recommended for?
A: They are primarily indicated for the treatment of thrombocytopenia in adults, especially those with chronic immune thrombocytopenia or thrombocytopenia associated with Hepatitis C infection.
Q: When should Eltrombopag use be avoided?
A: Eltrombopag is contraindicated during pregnancy or breastfeeding unless your physician decides the benefits outweigh the risks. Discuss your medical history and any current conditions with your doctor before starting therapy.
Q: What are common side effects of Eltrombopag Tablets?
A: Some potential side effects include nausea, diarrhea, headache, and abnormalities in liver enzymes. Report any persistent or severe symptoms to your physician promptly.
Q: Where should I store Eltrombopag Tablets?
A: Store the tablets below 30C, in a dry environment, and away from direct light. Ensure the medication is kept in its original packaging to maintain potency and safety.
Q: What are the benefits of using Eltrombopag Tablets?
A: Eltrombopag effectively increases platelet counts, reducing bleeding risks linked with chronic immune thrombocytopenia or Hepatitis C-associated thrombocytopenia, which can significantly improve quality of life when used under medical supervision.